Laboratory Test Preparation

| Test | : | Estrogen (RIA) |
| Other Test Request Name | : | Not applicable |
| Test Composition | : | Not applicable |
| Intended Use | : | Estrogens are secreted by the gonads, adrenal glands, and placenta. Total estrogens provide an overall picture of estrogen status for men and women. |
| Methodology | : | Radioimmunoassay (RIA) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 4 Days |
| • Refrigerated Temperature (2-8°C) | : | 14 Days |
| • Freezer Temperature (-20°C) | : | 28 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Batch Running |
| Cut Off Time | : | Monday, 12:00 PM
|
| TAT/Releasing of Results | : | 2 weeks after cut-off (excluding saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Estrogen Fractions/fractionated; Estrone (E1); Estradiol (E2); Estriol (E3); Estrogenic Hormones, Estrogens; Estrone; Estradiol; Estriol |
| Test | : | Estrogen Fractionated |
| Other Test Request Name | : | Not applicable |
| Test Composition | : | • Estriol |
| Intended Use | : | • Aid in evaluation of secondary amenorrhea and gonadotropin deficiency. |
| Methodology | : | Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red tube (DO NOT USE GOLD TUBE or any other type of tube with gel separator) |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 48 Hours |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 2 Years |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Batch Running |
| Cut Off Time | : | Monday, 12:00 PM
|
| TAT/Releasing of Results | : | 2 weeks after cut-off (excluding saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Estrogen Fractions/fractionated; Estrone (E1); Estradiol (E2); Estriol (E3); Estrogenic Hormones, Estrogens; Estrone; Estradiol; Estriol |
| Test | : | Factor 11(FOR HP DEL MONTE ONLY) |
| Other Test Request Name | : |
|
| Test Composition | : | Not Applicable |
| Intended Use | : | Useful on diagnosing Haemophilia B. Investigation of prolonged APTT. Assessing impact of liver diease on hemostasis. |
| Methodology | : | Fibrin Clot Method |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
|
| Collection/Sample Container | : | Citrated Tube or Blue Top |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Plasma |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Applicable |
| • Refrigerated Temperature (2-8°C) | : | Not Applicable |
| • Freezer Temperature (-20°C) | : | 1 Hour |
| Transport Temperature | : | Transport specimen at -20 °C (with dry ice) |
| Rejection Criteria | : |
|
| Running Day | : | Monday to Friday |
| Cut Off Time | : | Monday to Friday, 7:00 AM |
| TAT/Releasing of Results | : | 3 days after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Blood coagulation abnormality |
| Test | : | Factor 12 (FOR HP DEL MONTE ONLY) |
| Other Test Request Name | : |
|
| Test Composition | : | Not Applicable |
| Intended Use | : | Factor XII deficiency (usually qualitative) is an autosomal recessive trait. Heterozygotes have Factor XII levels of anywhere between 15 and 80% of the normal level while homozygotes have less than 1%. It has been clearly established that such deficiency is not associated with a tendency to hemorrhage although an increased predisposition to thrombosis remains possible because the main role played by Factor XII in hemostasis is to promote fibrinolysis.Levels of Factor XII in the blood may rise dramatically after intense physical exercise. |
| Methodology | : | Fibrin Clot Method |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
|
| Collection/Sample Container | : | Citrated Tube or Blue Top |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Plasma |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Applicable |
| • Refrigerated Temperature (2-8°C) | : | Not Applicable |
| • Freezer Temperature (-20°C) | : | 1 Hour |
| Transport Temperature | : | Transport specimen at -20 °C (with dry ice) |
| Rejection Criteria | : |
|
| Running Day | : | Monday to Friday |
| Cut Off Time | : | Monday to Friday, 7:00 AM |
| TAT/Releasing of Results | : | 3 days after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Factor Assays, Blood Clotting Factors, Clotting Factors |
| Test | : | Factor 5 (FOR HP DEL MONTE ONLY) |
| Other Test Request Name | : |
|
| Test Composition | : | Not Applicable |
| Intended Use | : | A protein made in your liver that helps convert prothrombin into thrombin. |
| Methodology | : | Fibrin Clot Method |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
|
| Collection/Sample Container | : | Blue or Citrated Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Plasma |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Applicable |
| • Refrigerated Temperature (2-8°C) | : | Not Applicable |
| • Freezer Temperature (-20°C) | : | 1 Hour |
| Transport Temperature | : | Transport specimen at -20 °C (with dry ice) |
| Rejection Criteria | : |
|
| Running Day | : | Monday to Friday |
| Cut Off Time | : | Monday to Friday, 7:00 AM |
| TAT/Releasing of Results | : | 3 days after cut-off (excluding saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Activated Protein C Resistance, APC Resistance, Factor V R506Q, PT G20210A, Factor II 20210, Factor II Mut, Factor V Leiden Mutation, Prothrombin 20210 Mutation |
| Test | : | Factor 5 (LEIDEN) (FOR HP DEL MONTE ONLY) |
| Other Test Request Name | : |
|
| Test Composition | : | Not Applicable |
| Intended Use | : | Factor V (Leiden) Mutation is a point mutation that causes resistance of factor V protein degradation by Activated protein C (APC). This mutation is associated with increased risk of venous thrombosis. |
| Methodology | : | Fibrin Clot Method |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
NOTE: Blood sample will be drawn every Wednesday from 6am only. |
| Collection/Sample Container | : | Blue or Citrated Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Plasma |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Applicable |
| • Refrigerated Temperature (2-8°C) | : | 1 Hour |
| • Freezer Temperature (-20°C) | : | Not Applicable |
| Transport Temperature | : | Transport specimen at 2°C - 8°C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Wednesday |
| Cut Off Time | : | Wednesday Only, 7:00 AM |
| TAT/Releasing of Results | : | 3 days after cut-off (excluding saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Activated Protein C Resistance; APC Resistance; Factor V R506Q; PT G20210A; Factor II 20210; Factor II Mut, Factor V Leiden Mutation; Prothrombin 20210 Mutation |
| Test | : | Factor 7 (FOR HP DEL MONTE ONLY) |
| Other Test Request Name | : |
|
| Test Composition | : | Not Applicable |
| Intended Use | : | A coagulation factor synthesized in the liver and carboxylated in a vitamin K-dependent reaction. Hereditary deficiency is very rare and the heterozygous state usually asymptomatic with about 30% of normal levels. Different forms of deficiency have been reported. Acquired deficiency is more common and can be caused by fibrinolysis, diffuse intravascular coagulation, vitamin K antagonist drugs, inadequate absorption or intake of vitamin K and liver disease. Increased Factor VII levels have been observed during episodes of arterial thrombosis. |
| Methodology | : | Fibrin Clot Method |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
|
| Collection/Sample Container | : | Blue or Citrated Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 4 mL Plasma |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not applicable |
| • Refrigerated Temperature (2-8°C) | : | 1 Hour |
| • Freezer Temperature (-20°C) | : | Not Applicable |
| Transport Temperature | : | Transport specimen at 2°C - 8°C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Monday to Friday |
| Cut Off Time | : | Monday to Friday, 7:00 AM |
| TAT/Releasing of Results | : | 3 days after cut-off (excluding saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Factor Assays, Blood Clotting Factors, Clotting Factors |
| Test | : | Factor 8 (FOR HP DEL MONTE ONLY) |
| Other Test Request Name | : | Anti-Hemophilic Factor |
| Test Composition | : | Not Applicable |
| Intended Use | : | Useful in diagnosing Haemophilia A, Von Willlebrand disease and investigation of prolonged APTT. |
| Methodology | : | Fibrin Clot Method |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
|
| Collection/Sample Container | : | Citrated Tube or Blue Top |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Plasma |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Applicable |
| • Refrigerated Temperature (2-8°C) | : | Not Applicable |
| • Freezer Temperature (-20°C) | : | 1 Hour |
| Transport Temperature | : | Transport specimen at -20 °C (with dry ice) |
| Rejection Criteria | : |
|
| Running Day | : | Monday to Friday |
| Cut Off Time | : | Monday to Friday, 7:00 AM |
| TAT/Releasing of Results | : | 3 days after cut-off (excluding saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Factor Assays, Blood Clotting Factors, Clotting Factors |
| Test | : | Factor 9 (FOR HP DEL MONTE ONLY) |
| Other Test Request Name | : |
|
| Test Composition | : | Not Applicable |
| Intended Use | : | Useful in diagnosing Haemophilia B, investigation of prolonged APTT and assessing impact of liver diease on hemostasis. |
| Methodology | : | Fibrin Clot Method |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
|
| Collection/Sample Container | : | Citrated Tube or Blue Top |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Plasma |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Applicable |
| • Refrigerated Temperature (2-8°C) | : | Not Applicable |
| • Freezer Temperature (-20°C) | : | 1 Hour |
| Transport Temperature | : | Transport specimen at -20 °C (with dry ice) |
| Rejection Criteria | : |
|
| Running Day | : | Monday to Friday |
| Cut Off Time | : | Monday to Friday, 7:00 AM |
| TAT/Releasing of Results | : | 3 days after cut-off (excluding saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Factor Assays, Blood Clotting Factors, Clotting Factors |
| Test | : | Factor IX Inhibitor |
| Other Test Request Name | : | Anti-Factor IX Antibodies Screening
|
| Test Composition | : | Not Applicable |
| Intended Use | : | Factor IX inhibitors arise in patients with severe hemophilia B after factor IX transfusion. Patients with factor IX inhibitors may also develop anaphylactic reactions in response to factor IX infusions. Acquired factor IX inhibitors, occurring in previously healthy people, are exceedingly rare. |
| Methodology | : | Chronometric |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
|
| Collection/Sample Container | : | Blue or Citrated Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 4 mL Plasma |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not Applicable |
| • Refrigerated Temperature (2-8°C) | : | 24 Hours |
| • Freezer Temperature (-20°C) | : | 28 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday, 12:00 PM |
| TAT/Releasing of Results | : | 2 weeks after cut-off (excluding saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Activated Partial Thromboplastin Time; aPTT; APTT, Partial Thromboplastin Time |
| Test | : | Factor Xa (Currently Not Accepting samples) |
| Other Test Request Name | : | • Factor X Functional • Stuart-Prower Factor |
| Test Composition | : | Not applicable |
| Intended Use | : | • Congenital Factor X deficiency is an autosomal recessive trait. Severe deficiency (i.e. the homozygous state or complementary mutations in the same gene) is rare. Heterozygotes only hemorrhage following serious trauma, e.g. surgery. Replacement therapy (by PPSB-SD) should aim at keeping Factor X levels above 25% of the normal level.Acquired Factor X deficiency is sometimes secondary to vitamin K deficiency in which case there is concomitant deficiency in Factors II, VII and IX; this can be induced by vitamin K antagonist drugs or by inadequate intake or absorption of this vitamin. Acquired Factor V deficiency may also be associated with liver disease, fibrinolysis and diffuse intravascular coagulation. In this case, deficiencies will also be observed in Factors II, V and VII. Isolated Factor X deficiency has been reported in amyloidosis. |
| Methodology | : | Fibrin Clot Method |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | • No patient preparation necessary. |
| Collection/Sample Container | : | Blue or Citrated Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 5 mL Plasma (Plastic Tube) |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not applicable |
| • Refrigerated Temperature (2-8°C) | : | 8 Hours |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Batch Running |
| Cut Off Time | : | 4:00 PM |
| TAT/Releasing of Results | : | 14 working days (excluding saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request. |
| Limitations/Interferences | : | None specified |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Not Applicable |
| Test | : | Fatty Acid w/ Long Chain |
| Other Test Request Name | : |
|
| Test Composition | : | Not Applicable |
| Intended Use | : | Peroxisomes play a vital role in several metabolic pathways, including the synthesis of plasmalogens and bile acids. Involved in the catabolism of Very Long Chain Fatty Acids (VLCFAs), phytanic acid, and pristanic acid. |
| Methodology | : | Chromatography - Colorimetry |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | 2 pcs of 4 ML EDTA tube or Violet Top |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 4 mL EDTA Plasma |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 1 Hour |
| • Refrigerated Temperature (2-8°C) | : | 5 Days |
| • Freezer Temperature (-20°C) | : | 28 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday, 12:00 PM |
| TAT/Releasing of Results | : | 4 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Peroxisomal Disease |
| Test | : | FBS/FPG (HEXOKINASE) |
| Other Test Request Name | : |
|
| Test Composition | : | Not applicable |
| Intended Use | : | FBS is a test that determines how much sugar is in a blood sample after a period of fasting. This is commonly used to detect and monitor diabetes mellitus. |
| Methodology | : | Hexokinase |
| Laboratory Section | : | Chemistry |
| Special Instructions/Patient Preparations | : | 8-12 hours fasting. |
| Collection/Sample Container | : | FBS/OGTFB - Red or Gold tube FPGLUC- Gray tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1-3 mL Serum |
| Alternative Specimen and Volume Requirement | : | 1-3mL Plasma (Li-heparin and K2-EDTA, NaF/Na2 EDTA, KF/Na2 EDTA, NaF/K-Oxalate and NaF/citrate/Na2EDTA) |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Serum (no hemolysis): 8 hours |
| • Refrigerated Temperature (2-8°C) | : | 72 Hours |
| • Freezer Temperature (-20°C) | : | Not specified |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday:6:00 PM |
| TAT/Releasing of Results | : | RUNNING TIME: 6:00 AM onwards ROUTINE:4 hours after receipt of specimen/ arrival of messenger STAT: After 2½ hours from extraction/messenger arrival |
| Reference Interval/Result Interpretation | : | 1 Day to 2 Y/O: 1.80~6.20 mmol/L (33.00~111.00 mg/dL) |
| Limitations/Interferences | : | In very rare cases, gammopathy, in particular type IgM (Waldenstrom’s |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | HbA1c, Urinalysis, Insulin, C-peptide, Urine Albumin, Comprehensive Metabolic Panel, Basic Metabolic Panel, Fructosamine |
| Test | : | Fecalysis w/ Parasite Ct |
| Other Test Request Name | : | Stool exam with parasite quantification |
| Test Composition | : | Physical Exam |
| Intended Use | : | For quantitation of parasites found in fecal specimens from the intestinal tract |
| Methodology | : | Direct Fecal Smear (NSS and Lugol's) |
| Laboratory Section | : | Clinical Microscopy |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Clean, leak-proof container |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | Pea sized or size of 25 centavo coin stool |
| Alternative Specimen and Volume Requirement | : | Not applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Liquid: 30 Minutes |
| • Refrigerated Temperature (2-8°C) | : | Not specified |
| • Freezer Temperature (-20°C) | : | Unacceptable |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Improperly labeled specimen container |
| Running Day | : | Daily |
| Cut Off Time | : | Monday to Saturday |
| TAT/Releasing of Results | : | ROUTINE |
| Reference Interval/Result Interpretation | : | NO INTERTINAL PARASITE SEEN |
| Limitations/Interferences | : | Samples which exceeded sample stability prior to examination may produce erroneous results. |
| Frequently Asked Questions (FAQs) | : | Q: Is specimen collected in diaper be acceptable? |
| Related Words/Test | : | Diarrhea |
| Test | : | Ferritin (CMIA) |
| Other Test Request Name | : | Serum Ferritin |
| Test Composition | : | Not applicable |
| Intended Use | : | Used in the evaluation of iron deficiency and Iron Overload |
| Methodology | : | Chemiluminescent Microparticle Immunoassay (CMIA) |
| Laboratory Section | : | Immunology |
| Special Instructions/Patient Preparations | : | • No fasting requirement. |
| Collection/Sample Container | : | Red or Gold tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1-3 mL Serum |
| Alternative Specimen and Volume Requirement | : | 1-3 mL Plasma (K3-EDTA, Li-Heparin) |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not specified |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 12 Months |
| Transport Temperature | : | Transport specimen at 2°C – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Monday - Saturday |
| Cut Off Time | : | Monday to Saturday:6:00 PM
|
| TAT/Releasing of Results | : | Monday - Saturday |
| Reference Interval/Result Interpretation | : | MALE: 21.81-274.66 ug/L |
| Limitations/Interferences | : | • Specimens from patients who have received preparations of mouse monoclonal antibodies for diagnosis or therapy may contain human anti-mouse antibodies (HAMA). Specimens containing HAMA may produce anomalous values when tested with assay kits that employ mouse monoclonal antibodies. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Complete Blood Count, Hemoglobin, Hematocrit, Serum Iron, TIBC, Transferrin, Iron Tests, Zinc Protoporphyrin, Soluble Transferrin Receptor |